ATCC Names Dr. Mindy Goldsborough as Chief Science and Technology Officer
Position strengthens ATCC’s product and technology development capabilities
Manassas, VA, United StatesMay 12, 2016
ATCC, a global leader in biological materials management and standards, today announced the appointment of Dr. Mindy Goldsborough as Chief Science and Technology Officer (CSTO). In this role, she will develop and execute ATCC’s overall scientific and technology strategy, including guidance and input on product development, technology assessment and development, and intellectual property as well as quality/regulatory and bioproduction/operations activities from a science and technology perspective.
“With more than 25 years of product and technology development experience within the life science and biotech industries, Mindy is the perfect choice for leading our scientific and technology strategy,” said Dr. Raymond H. Cypess, ATCC Chairman and CEO. “Her expertise in cell and molecular biology will help guide our science and technology roadmap, and ensure that we are investing in the right products and technologies to support our overall mission, strategy, and competitive advantage.”
Dr. Goldsborough, who joined ATCC in 2012, will maintain her current role as Vice President and General Manager of ATCC Cell Systems (ACS), ATCC’s research and development (R&D) business focused on optimizing and innovating cell- and cell biology-based products. In this role, she is responsible for the overall strategy, management, and growth of ACS.
Prior to ATCC, Dr. Goldsborough was Director of R&D for BD Biosciences’ Advanced Bioprocessing group, where she developed media and supplements for biologic and vaccine drug manufacturing and cell therapy applications. Her previous work includes senior R&D roles at BD Biosciences’ Bioimaging business (formerly Atto Biosciences) and Life Technologies, where she led R&D efforts in DNA-based diagnostics, stem cell biology, forensics, and nucleic acid purification.
Dr. Goldsborough earned her Ph.D. in Genetics from The George Washington University, and completed her dissertation research and post-doctoral work at The National Institutes of Health, National Cancer Institute.
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. With a history of scientific advancements spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological research solutions and a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, and people provide the scientific community with credible biological products, advanced model systems, and custom solutions that support complex research in a variety of innovative applications resulting in incredible achievements in basic science, drug discovery, translational medicine, and public health. ATCC is a non-profit organization with headquarters in Manassas, VA, and an R&D innovation center in Gaithersburg, MD.
Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, 703-365-2700 ext. 2753